San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Cytovale is raising $8,010,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ajay Shah played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cytovale

At Cytovale, we apply machine learning, high-speed imaging and microfluidics to detect disease in real time. Interrogating thousands of cells per second, we can rapidly build multi-dimensional representations of the host immune state to identify disease signatures indicative of sepsis. Within less than ten minutes, our system will provide clinicians with actionable information to aid in diagnosis and inform treatment. At Cytovale we start with the patient, not the pathogen, to develop solutions for early detection of sepsis that would enable clinicians to provide early treatment, which is crucial to patient survival.

To learn more about Cytovale, visit http://cytovale.com/

Contact:
Ajay Shah, Chief Executive Officer
562-881-6919
ajay.shah@cytovale.com
https://www.linkedin.com/in/ajaymukeshshah/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved